This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
|Articles|June 12, 2007
Welcome to Drug Topics' Publisher's Blog
To get your feedback on what’s happening in pharmacy, Drug Topics has set up a blog for its publisher, Joe Laborsky, R.Ph. The first blog, about drug errors, is a response to the recent ABC “20/20” show on the subject.
Advertisement
To get your feedback on whats happening in pharmacy, Drug Topics has set up a blog for its publisher, Joe Laborsky, R.Ph. The first blog, about drug errors, is a response to the recent ABC 20/20 show on the subject. It also sets the stage for a roundtable discussion entitled Error-proofing your pharmacy that Drug Topics will be holding at the ASHP summer meeting in San Francisco this month. To visit our publishers blog, click
Advertisement
Related to this article
A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.
Menopause status and symptoms are inconsistently captured in electronic health records, leaving a gap in care for patients.
As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.
Eli Lilly’s new indication helps improve medication delivery for adults with type 2 diabetes, reducing annual injections by over 300.
Pennsylvania has become the center of the outbreak as cases exceed 775 alongside conflicting mortality reports.
Advertisement
Advertisement
Trending on Drug Topics
1
Study Finds Reduced Cardiovascular Risk With Hormone Therapy Initiation
2
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
3
FDA Approves Onswik Weekly Insulin for Adults With T2D
4
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
5